Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Electrical stimulation or moisture infusion improves the eating quality attributes of loin and silverside cuts from female and immunocastrated male pigs.

Channon HA, D'Souza DN, Dunshea FR.

Meat Sci. 2018 Sep;143:257-267. doi: 10.1016/j.meatsci.2018.05.001. Epub 2018 May 3.

PMID:
29857268
2.

Guaranteeing the quality and integrity of pork - An Australian case study.

Channon HA, D'Souza DN, Jarrett RG, Lee GSH, Watling RJ, Jolley JYC, Dunshea FR.

Meat Sci. 2018 Oct;144:186-192. doi: 10.1016/j.meatsci.2018.04.030. Epub 2018 Apr 27. Review.

PMID:
29735356
3.

Validating post-slaughter interventions to produce consistently high quality pork cuts from female and immunocastrated male pigs.

Channon HA, D'Souza DN, Dunshea FR.

Meat Sci. 2018 Aug;142:14-22. doi: 10.1016/j.meatsci.2018.03.021. Epub 2018 Mar 28.

PMID:
29635218
4.

Eating quality traits of shoulder roast and stir fry cuts outperformed loin and silverside cuts sourced from entire and immunocastrated male pigs.

Channon HA, D'Souza DN, Dunshea FR.

Meat Sci. 2018 Feb;136:104-115. doi: 10.1016/j.meatsci.2017.10.019. Epub 2017 Oct 31.

PMID:
29121524
5.

Diet composition and slaughter age up to 24weeks have minimal impact on pork eating quality of loin steaks and silverside roasts from female pigs.

Channon HA, D'Souza DN, Dunshea FR.

Meat Sci. 2018 Jan;135:94-101. doi: 10.1016/j.meatsci.2017.09.005. Epub 2017 Sep 18.

PMID:
28965019
6.

A phase 1 study of the Janus kinase 2 (JAK2)V617F inhibitor, gandotinib (LY2784544), in patients with primary myelofibrosis, polycythemia vera, and essential thrombocythemia.

Verstovsek S, Mesa RA, Salama ME, Li L, Pitou C, Nunes FP, Price GL, Giles JL, D'Souza DN, Walgren RA, Prchal JT.

Leuk Res. 2017 Oct;61:89-95. doi: 10.1016/j.leukres.2017.08.010. Epub 2017 Aug 31.

PMID:
28934680
7.

Quality of life in children and adolescents with bipolar I depression treated with olanzapine/fluoxetine combination.

Walker DJ, DelBello MP, Landry J, D'Souza DN, Detke HC.

Child Adolesc Psychiatry Ment Health. 2017 Jul 12;11:34. doi: 10.1186/s13034-017-0170-7. eCollection 2017.

8.

Developing a cuts-based system to improve consumer acceptability of pork: Impact of gender, ageing period, endpoint temperature and cooking method.

Channon HA, D'Souza DN, Dunshea FR.

Meat Sci. 2016 Nov;121:216-227. doi: 10.1016/j.meatsci.2016.06.011. Epub 2016 Jun 14.

PMID:
27348320
9.

Florbetapir F18 PET Amyloid Neuroimaging and Characteristics in Patients With Mild and Moderate Alzheimer Dementia.

Degenhardt EK, Witte MM, Case MG, Yu P, Henley DB, Hochstetler HM, D'Souza DN, Trzepacz PT.

Psychosomatics. 2016 Mar-Apr;57(2):208-16. doi: 10.1016/j.psym.2015.12.002. Epub 2015 Dec 3.

10.

Estimating the impact of various pathway parameters on tenderness, flavour and juiciness of pork using Monte Carlo simulation methods.

Channon HA, Hamilton AJ, D'Souza DN, Dunshea FR.

Meat Sci. 2016 Jun;116:58-66. doi: 10.1016/j.meatsci.2016.01.004. Epub 2016 Jan 26.

PMID:
26869282
11.

Dietary Lecithin Supplementation Can Improve the Quality of the M. Longissimus thoracis.

D'Souza DN, Blake BL, Williams IH, Mullan BP, Pethick DW, Dunshea FR.

Animals (Basel). 2015 Nov 25;5(4):1180-91. doi: 10.3390/ani5040405.

12.

A double-blind, placebo-controlled study of edivoxetine as an adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment.

Ball S, Dellva MA, D'Souza DN, Marangell LB, Russell JM, Goldberger C.

J Affect Disord. 2014;167:215-23. doi: 10.1016/j.jad.2014.06.006. Epub 2014 Jun 14.

PMID:
24995890
13.

A randomized trial of edivoxetine in pediatric patients with attention-deficit/hyperactivity disorder.

Lin DY, Kratochvil CJ, Xu W, Jin L, D'Souza DN, Kielbasa W, Allen AJ.

J Child Adolesc Psychopharmacol. 2014 May;24(4):190-200. doi: 10.1089/cap.2013.0043.

14.

Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: results of double-blind and open-label cross-over trials of insulin lispro and insulin aspart.

Tamborlane WV, Renard E, Wadwa RP, Blevins T, Jacober SJ, Liu R, D'Souza DN, Rees TM.

J Diabetes. 2015 Mar;7(2):270-8. doi: 10.1111/1753-0407.12162. Epub 2014 May 22.

PMID:
24734891
15.

Dietary lecithin improves dressing percentage and decreases chewiness in the longissimus muscle in finisher gilts.

Akit H, Collins CL, Fahri FT, Hung AT, D'Souza DN, Leury BJ, Dunshea FR.

Meat Sci. 2014 Mar;96(3):1147-51. doi: 10.1016/j.meatsci.2013.10.028. Epub 2013 Oct 29.

PMID:
24334033
16.

Aitchbone hanging and ageing period are additive factors influencing pork eating quality.

Channon HA, Taverner MR, D'Souza DN, Warner RD.

Meat Sci. 2014 Jan;96(1):581-90. doi: 10.1016/j.meatsci.2013.08.016. Epub 2013 Aug 14.

PMID:
24013699
17.

Responsiveness of the Intermittent and Constant Osteoarthritis Pain (ICOAP) scale in a trial of duloxetine for treatment of osteoarthritis knee pain.

Risser RC, Hochberg MC, Gaynor PJ, D'Souza DN, Frakes EP.

Osteoarthritis Cartilage. 2013 May;21(5):691-4. doi: 10.1016/j.joca.2013.02.007. Epub 2013 Feb 26.

18.

The interaction between ractopamine supplementation, porcine somatotropin and moisture infusion on pork quality.

Moore KL, Mullan BP, D'Souza DN.

Meat Sci. 2012 Oct;92(2):125-31. doi: 10.1016/j.meatsci.2012.04.022. Epub 2012 Apr 23.

PMID:
22580090
19.

Atomoxetine treatment outcomes in adolescents and young adults with attention-deficit/hyperactivity disorder: results from a post hoc, pooled analysis.

Adler LA, Wilens T, Zhang S, Dittmann RW, D'Souza DN, Schuh L, Durell TM.

Clin Ther. 2012 Feb;34(2):363-73. doi: 10.1016/j.clinthera.2011.12.015. Epub 2012 Jan 27.

PMID:
22285724
20.

Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine.

Wilens TE, Adler LA, Tanaka Y, Xiao F, D'Souza DN, Gutkin SW, Upadhyaya HP.

Curr Med Res Opin. 2011 Dec;27(12):2309-20. doi: 10.1185/03007995.2011.628648. Epub 2011 Oct 27.

21.

A randomized, double-blind study comparing LY2216684 and placebo in the treatment of major depressive disorder.

Pangallo B, Dellva MA, D'Souza DN, Essink B, Russell J, Goldberger C.

J Psychiatr Res. 2011 Jun;45(6):748-55. doi: 10.1016/j.jpsychires.2011.03.014. Epub 2011 Apr 21.

PMID:
21511276
22.

Effect of duloxetine in patients with fibromyalgia: tiredness subgroups.

Bradley LA, Bennett R, Russell IJ, Wohlreich MM, Chappell AS, Wang F, D'Souza DN, Moldofsky H.

Arthritis Res Ther. 2010;12(4):R141. doi: 10.1186/ar3081. Epub 2010 Jul 14.

23.

Pain response profile of patients with fibromyalgia treated with duloxetine.

Bradley LA, Wohlreich MM, Wang F, Gaynor PJ, Robinson MJ, D'Souza DN, Mease PJ.

Clin J Pain. 2010 Jul-Aug;26(6):498-504. doi: 10.1097/AJP.0b013e3181dee80e.

PMID:
20551724
24.

Relationship between atomoxetine plasma concentration, treatment response and tolerability in attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder.

Hazell P, Becker K, Nikkanen EA, Trzepacz PT, Tanaka Y, Tabas L, D'Souza DN, Witcher J, Long A, Ponsler G, Dittmann RW.

Atten Defic Hyperact Disord. 2009 Dec;1(2):201-10. doi: 10.1007/s12402-009-0012-4. Epub 2009 Sep 23.

25.

Characteristics of placebo responders in pediatric clinical trials of attention-deficit/hyperactivity disorder.

Newcorn JH, Sutton VK, Zhang S, Wilens T, Kratochvil C, Emslie GJ, D'souza DN, Schuh LM, Allen AJ.

J Am Acad Child Adolesc Psychiatry. 2009 Dec;48(12):1165-72. doi: 10.1097/CHI.0b013e3181bc730d.

PMID:
19858759
26.

A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia.

Chappell AS, Littlejohn G, Kajdasz DK, Scheinberg M, D'Souza DN, Moldofsky H.

Clin J Pain. 2009 Jun;25(5):365-75. doi: 10.1097/AJP.0b013e31819be587.

PMID:
19454869
27.

A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia.

Chappell AS, Bradley LA, Wiltse C, Detke MJ, D'Souza DN, Spaeth M.

Int J Gen Med. 2008 Nov 30;1:91-102.

28.

Levels of copper and zinc in diets for growing and finishing pigs can be reduced without detrimental effects on production and mineral status.

Hernández A, Pluske JR, D'Souza DN, Mullan BP.

Animal. 2008 Dec;2(12):1763-71. doi: 10.1017/S1751731108003182.

PMID:
22444082
29.

Effects of continual fluctuation in feed intake on growth performance response and carcass fat-to-lean ratio in grower-finisher pigs.

Mullan BP, Trezona M, D'Souza DN, Kim JC.

J Anim Sci. 2009 Jan;87(1):179-88. doi: 10.2527/jas.2008-1041. Epub 2008 Sep 2.

PMID:
18765851
30.

Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources.

Strombom I, Wernicke JF, Seeger J, D'Souza DN, Acharya N.

Curr Drug Saf. 2008 May;3(2):154-62.

PMID:
18690993
31.

Hepatic effects of duloxetine-II: spontaneous reports and epidemiology of hepatic events.

Wernicke J, Acharya N, Strombom I, Gahimer JL, D'Souza DN, DiPietro N, Uetrecht JP.

Curr Drug Saf. 2008 May;3(2):143-53. Review.

PMID:
18690992
32.

Hepatic effects of duloxetine-I: non-clinical and clinical trial data.

Wernicke J, Pangallo B, Wang F, Murray I, Henck JW, Knadler MP, D'Souza DN, Uetrecht JP.

Curr Drug Saf. 2008 May;3(2):132-42. Review. Erratum in: Curr Drug Saf. 2009 Jan;4(1):94.

PMID:
18690991
33.

5-HT1A receptors mediate (+)8-OH-DPAT-stimulation of extracellular signal-regulated kinase (MAP kinase) in vivo in rat hypothalamus: time dependence and regional differences.

Crane JW, Shimizu K, Carrasco GA, Garcia F, Jia C, Sullivan NR, D'Souza DN, Zhang Y, Van de Kar LD, Muma NA, Battaglia G.

Brain Res. 2007 Dec 5;1183:51-9. Epub 2007 Sep 29.

PMID:
17976547
34.

Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials.

Arnold LM, Pritchett YL, D'Souza DN, Kajdasz DK, Iyengar S, Wernicke JF.

J Womens Health (Larchmt). 2007 Oct;16(8):1145-56.

PMID:
17937567
35.

An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.

Wernicke JF, Wang F, Pritchett YL, Smith TR, Raskin J, D'Souza DN, Iyengar S, Chappell AS.

Pain Med. 2007 Sep;8(6):503-13.

PMID:
17716324
36.

Chronic olanzapine activates the Stat3 signal transduction pathway and alters expression of components of the 5-HT2A receptor signaling system in rat frontal cortex.

Muma NA, Singh RK, Vercillo MS, D'Souza DN, Zemaitaitis B, Garcia F, Damjanoska KJ, Zhang Y, Battaglia G, Van de Kar LD.

Neuropharmacology. 2007 Sep;53(4):552-62. Epub 2007 Jul 1.

37.

Duloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomes.

Armstrong DG, Chappell AS, Le TK, Kajdasz DK, Backonja M, D'Souza DN, Russell JM.

Pain Med. 2007 Jul-Aug;8(5):410-8. Erratum in: Pain Med. 2007 Nov-Dec;8(8):690.

PMID:
17661854
38.

Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.

Russell JM, Weisberg R, Fava M, Hartford JT, Erickson JS, D'Souza DN.

Depress Anxiety. 2008;25(7):E1-11.

PMID:
17587217
39.

Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder.

Acharya N, Rosen AS, Polzer JP, D'Souza DN, Perahia DG, Cavazzoni PA, Baldessarini RJ.

J Clin Psychopharmacol. 2006 Dec;26(6):587-94. Erratum in: J Clin Psychopharmacol. 2007 Feb;27(1):57.

PMID:
17110815
40.

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

Wernicke JF, Pritchett YL, D'Souza DN, Waninger A, Tran P, Iyengar S, Raskin J.

Neurology. 2006 Oct 24;67(8):1411-20.

PMID:
17060567
41.

Duloxetine in the long-term management of diabetic peripheral neuropathic pain: An open-label, 52-week extension of a randomized controlled clinical trial.

Wernicke JF, Raskin J, Rosen A, Pritchett YL, D'Souza DN, Iyengar S, Knopp K, Le TK.

Curr Ther Res Clin Exp. 2006 Sep;67(5):283-304. doi: 10.1016/j.curtheres.2006.10.001.

42.

Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.

Raskin J, Smith TR, Wong K, Pritchett YL, D'Souza DN, Iyengar S, Wernicke JF.

J Palliat Med. 2006 Feb;9(1):29-40.

PMID:
16430342
43.

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.

Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke JF.

Pain. 2005 Dec 15;119(1-3):5-15. Epub 2005 Nov 17.

PMID:
16298061
44.

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.

Raskin J, Pritchett YL, Wang F, D'Souza DN, Waninger AL, Iyengar S, Wernicke JF.

Pain Med. 2005 Sep-Oct;6(5):346-56.

PMID:
16266355
45.

Effects of dietary factors and other metabolic modifiers on quality and nutritional value of meat.

Dunshea FR, D'Souza DN, Pethick DW, Harper GS, Warner RD.

Meat Sci. 2005 Sep;71(1):8-38. doi: 10.1016/j.meatsci.2005.05.001. Epub 2005 Jun 27.

PMID:
22064049
46.

Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression.

Dunner DL, D'Souza DN, Kajdasz DK, Detke MJ, Russell JM.

J Affect Disord. 2005 Jul;87(1):115-9. Review.

PMID:
15967235
47.

Tandospirone activates neuroendocrine and ERK (MAP kinase) signaling pathways specifically through 5-HT1A receptor mechanisms in vivo.

Sullivan NR, Crane JW, Damjanoska KJ, Carrasco GA, D'Souza DN, Garcia F, Van de Kar LD.

Naunyn Schmiedebergs Arch Pharmacol. 2005 Jan;371(1):18-26. Epub 2005 Jan 18.

PMID:
15655673
48.

Estrogen reduces serotonin-1A receptor-mediated oxytocin release and Galpha(i/o/z) proteins in the hypothalamus of ovariectomized rats.

D'Souza DN, Zhang Y, Damjanoska KJ, Carrasco GA, Sullivan NR, Garcia F, Battaglia G, Doncarlos LL, Muma NA, Van de Kar LD.

Neuroendocrinology. 2004;80(1):31-41.

PMID:
15385710
49.

Estrogen treatment increases the levels of regulator of G protein signaling-Z1 in the hypothalamic paraventricular nucleus: possible role in desensitization of 5-hydroxytryptamine1A receptors.

Carrasco GA, Barker SA, Zhang Y, Damjanoska KJ, Sullivan NR, Garcia F, D'souza DN, Muma NA, van De Kar LD.

Neuroscience. 2004;127(2):261-7.

PMID:
15262317
50.

Short-term cocaine treatment causes neuroadaptive changes in Galphaq and Galpha11 proteins in rats undergoing withdrawal.

Carrasco GA, Damjanoska KJ, D'Souza DN, Zhang Y, Garcia F, Battaglia G, Muma NA, Van de Kar LD.

J Pharmacol Exp Ther. 2004 Oct;311(1):349-55. Epub 2004 Jun 2.

PMID:
15175423

Supplemental Content

Loading ...
Support Center